Raymond James & Associates’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,005
Closed -$94K 4180
2022
Q2
$94K Buy
12,005
+1,218
+11% +$10.5K ﹤0.01% 3688
2022
Q1
$120K Buy
+10,787
New +$121K ﹤0.01% 3787
2021
Q4
Sell
-10,155
Closed -$206K 4329
2021
Q3
$206K Sell
10,155
-20,684
-67% -$532K ﹤0.01% 3652
2021
Q2
$1.02M Sell
30,839
-6,123
-17% -$231K ﹤0.01% 2579
2021
Q1
$1.44M Buy
36,962
+2,040
+6% +$95.8K ﹤0.01% 2251
2020
Q4
$1.52M Sell
34,922
-13,162
-27% -$450K ﹤0.01% 2061
2020
Q3
$1.36M Buy
48,084
+40,574
+540% +$1.28M ﹤0.01% 1992
2020
Q2
$273K Buy
+7,510
New +$212K ﹤0.01% 2974

Other funds holding ONEM

Raymond James & Associates's ONEM Position: Q3 2022 in Review

Raymond James & Associates sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 12,005 shares — an estimated $94K sold.

Raymond James & Associates first reported a position in ONEM in Q2 2020 and held it in 8 quarters. The position peaked at $1.52M in Q4 2020. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Raymond James & Associates reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 12,005 1Life Healthcare shares in Q3 2022, an estimated $94K.
  • Raymond James & Associates first reported a position in 1Life Healthcare in Q2 2020 and held it in 8 quarters.
  • Raymond James & Associates's 1Life Healthcare position peaked at $1.52M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.